Guardant Health (MEX:GH) Stock Based Compensation: MXN3,221 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GH Guardant Health Inc MEX:GH
13 GF Score
Price MXN2,590.00
GF Value MXN998.88
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guardant Health Stock Based Compensation?

Guardant Health MEX:GH 13 Stock Based Compensation is MXN3,221 Mil as of Mar. 2026. GuruFocus rates MEX:GH with a GF Score™ of 13/100 and a GF Value™ of MXN998.88 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Guardant Health's Stock Based Compensation for the three months ended in Mar. 2026 was MXN859 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was MXN3,221 Mil.

Guardant Health Stock Based Compensation Related Terms

Guardant Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Guardant Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Stock Based Compensation Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,106.83 1,845.98 1,540.57 2,928.37 2,992.85

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 772.44 799.53 785.28 777.67 858.50
MEX:GH
13GF Score
Guardant Health Inc MEX:GH
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN3,221 Mil.

What does a Stock Based Compensation of MXN3,221 Mil mean?
Guardant Health (MEX:GH) has a Stock Based Compensation of MXN3,221 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Guardant Health and its competitors.
Is Guardant Health's Stock Based Compensation too high?
Guardant Health's current Stock Based Compensation is MXN3,221 Mil. Overall, Guardant Health has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Stock Based Compensation compare to LH and DGX?
Guardant Health's Stock Based Compensation of MXN3,221 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Diagnostics & Research company?
A good Stock Based Compensation depends on the Medical Diagnostics & Research industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Guardant Health and its competitors. Guardant Health's current Stock Based Compensation is MXN3,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (MEX:GH) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN998.88, compared to a current price of MXN2,590.00 — trading 159.3% above its estimated fair value. The current Stock Based Compensation is MXN3,221 Mil. Guardant Health's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Stock Based Compensation is MXN3,221 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,590.00 is trading 159.3% above its estimated GF Value™ of MXN998.88. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for MEX:GH:

  • Stock Based Compensation: MXN3,221 Mil
  • GF Value™: MXN998.88 vs. price of MXN2,590.00 (159.3% above fair value)
  • GF Score™: 13/100 with 3 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
13GF Score

Get the complete analysis for MEX:GH

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,590.00
Price
MXN998.88
GF Value